S
Sandra S. Richter
Researcher at Cleveland Clinic
Publications - 121
Citations - 8141
Sandra S. Richter is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Population & Carbapenem-resistant enterobacteriaceae. The author has an hindex of 44, co-authored 118 publications receiving 7012 citations. Previous affiliations of Sandra S. Richter include BioMérieux & Roy J. and Lucille A. Carver College of Medicine.
Papers
More filters
Journal ArticleDOI
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a
Ellen Jo Baron,J. Michael Miller,Melvin P. Weinstein,Sandra S. Richter,Peter H. Gilligan,Richard B. Thomson,Paul P. Bourbeau,Karen C. Carroll,Sue C. Kehl,W. Michael Dunne,W. Michael Dunne,Barbara Robinson-Dunn,Joseph D. Schwartzman,Kimberle C. Chapin,James W. Snyder,Betty A. Forbes,Robin Patel,Jon E. Rosenblatt,Bobbi S. Pritt +18 more
TL;DR: This document, developed by both laboratory and clinical experts, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions.
Journal ArticleDOI
Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth
David A. Stoltz,David K. Meyerholz,Alejandro A. Pezzulo,Shyam Ramachandran,Mark P. Rogan,Greg J. Davis,Robert A. Hanfland,Chris Wohlford-Lenane,Cassie L. Dohrn,Jennifer A. Bartlett,George A. Nelson,Eugene H. Chang,Peter J. Taft,Paula S. Ludwig,Mira Estin,Emma E. Hornick,Janice L. Launspach,Melissa Samuel,Tatiana Rokhlina,Philip H. Karp,Lynda S. Ostedgaard,Aliye Uc,Timothy D. Starner,Alexander R. Horswill,Kim A. Brogden,Randall S. Prather,Sandra S. Richter,Joel Shilyansky,Paul B. McCray,Joseph Zabner,Michael J. Welsh +30 more
TL;DR: Findings in cystic fibrosis pigs that survive long enough to develop human-like lung disease are reported, suggesting that impaired bacterial elimination is the pathogenic event that initiates a cascade of inflammation and pathology in CF lungs.
Journal ArticleDOI
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin,Judith J. Lok,Michelle Earley,Eric Cober,Sandra S. Richter,Federico Perez,Federico Perez,Robert A. Salata,Robert C. Kalayjian,Richard R. Watkins,Richard R. Watkins,Yohei Doi,Keith S Kaye,Vance G. Fowler,David L. Paterson,Robert A. Bonomo,Robert A. Bonomo,Scott R. Evans +17 more
TL;DR: Ceftazidime-avibactam may be a reasonable alternative to colistin in the treatment of K. pneumoniae carbapenemase-producing CRE infections and require confirmation in a randomized controlled trial.
Journal ArticleDOI
Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases
Sandra S. Richter,Rudolph P. Galask,Shawn A. Messer,Richard J. Hollis,Daniel J. Diekema,Michael A. Pfaller +5 more
TL;DR: The results support the use of azoles for empirical therapy of uncomplicated candidal vulvovaginitis and suggest recurrent episodes are more often caused by non-albicans species, for which azole agents are less likely to be effective.
Journal ArticleDOI
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology
J. Michael Miller,Matthew J. Binnicker,Sheldon Campbell,Karen C. Carroll,Kimberle C. Chapin,Peter H. Gilligan,Mark D. Gonzalez,Robert C. Jerris,Sue C. Kehl,Robin Patel,Bobbi S. Pritt,Sandra S. Richter,Barbara Robinson-Dunn,Joseph D. Schwartzman,James W. Snyder,Sam R. Telford,Elitza S. Theel,Richard B. Thomson,Melvin P. Weinstein,Joseph D. Yao +19 more
TL;DR: This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions.